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ABSTRACT 
 
Galega officinalis Linn (Goat’s rue) is popularly called sakpani in Hausa speaking part of Nigeria. 
The Plant belongs to the family Leguminoseae. G. officinalis is chiefly used as an antidiabetic plant 
because of its ability to reduce blood sugar levels. The plant has positive effect on breast-milk 
production. Aqueous, methanolic, ethanolic and acetone extracts of the plant Galega officinalis Linn 
(Leguminoseae) and fractionations of the methanolic extracts were carried out in stages using 
standard procedures. Alkaloids, glycosides and flavonoids from the methanolic extracts of G. 
officinalis at 400 mg/kg body weight significantly (p<0.05) reduced the plasma glucose 
concentration in diabetic treated rats at the 3rd and 28th day of treatment when compared to diabetic 
untreated rats with alkaloids, glycosides and flavonoids producing 81.61%, 27.20% and 21.76% 
decreases in glucose concentrations. Also alkaloids from the methanolic extracts of G. officinalis 
improved lipid profile and reverse the adverse effects of induced diabetic on selected marker 
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enzymes. Methanolic fractions F1, F2, F3 and F6 produced remarkable effect by decreasing glucose 
concentration in diabetic treated rats compared to diabetic untreated rats. Methanolic extract of G. 
officinalis proved to be a rich source of phytochemicals with potent hypoglycaemic and 
hypolipidemic effects. 
 
 
Keywords: Galega officinalis; methanolic extracts; fractionation; diabetics; phytochemicals;   
hypoglycaemic potential. 
 
1. INTRODUCTION 
 
Plants as medicines have being practiced by 
man for the cure of several diseases for 
centuries [1,2,3]. At present, despite the 
abundance and advancement of synthetic drugs, 
a significant proportion of the population of 
developing countries still depend on traditional 
medicines for their health care needs [3]. 
According to World Health Organization 2001, 
60% of the world’s population depend on 
traditional medicine, and 80% of the population in 
developing countries depend almost entirely on 
traditional medical practices, in particular, herbal 
medicine for their primary health care needs 
[4,5]. In Traditional Chinese Medicine (TCM), for 
instance, the disease has been referred to as 
“Xiaokezheng” or “Xiaodanzheng,” both of which 
mean diabetes [6]. In the Sri Lankan traditional 
medicinal system, the disease has been stated 
as “Madhumeha” [7]. Plants have always been 
an exemplary source of drugs and have directly 
or indirectly yielded many important medicines in 
the past. For instance, the discovery of the 
widely used hypoglycemic drug, Metformin, came 
from the traditional approach of using Galega 
officinalis [3]. Overall, herbal remedies are 
gaining popularity because of several 
advantages such as a comparatively lower 
incidence of side-effects at recommended 
dosages, better patient tolerance, relatively low 
cost, and acceptance due to a long history of 
use. From the perspective of diabetes, the more 
important cause is that herbal medicines provide 
rational means for remedying the disease 
condition as well as many other ailments which 
are obstinate and incurable in more Western 
systems of medicine. Medicinal plants continue 
to contribute significantly to modern prescription 
of drugs by providing lead compounds upon 
which the synthesis of new drugs are made. [2] 
reported that 60% of the anticancer drugs and 
75% of the anti-infectious disease drugs 
approved from 1981-2002, could be traced to 
natural origins. In addition, 61% of all new 
chemical entities introduced worldwide as drugs 
during the same period could be traced to or 
were inspired by natural products [8]. 
 
Galega officinalis Linn (Goat’s rue) is popularly 
called sakpani in Hausa speaking part of Nigeria. 
The Plant belongs to the family Leguminoseae. 
G. officinalis is chiefly used as an antidiabetic 
plant because of its ability to reduce blood sugar 
levels. The plant has positive effect on breast-
milk production [9]. With over 800 herbal 
medicinal plants in use for the treatment of 
Diabetics [10], the search for active biomolecules 
from medicinal plants with anti-diabetic 
properties is still on. 
 
2. MATERIALS AND METHODS 
 
2.1 Plant Material 
 
The plant G. officinalis Linn (Goat’s rue, whole 
plant) was collected at Naraguta village, 
University of Jos permanent site, Plateau State, 
Nigeria. The plant was identified and 
authenticated at the Department of Plant Science 
and Technology, University of Jos, Nigeria. A 
Voucher sample was then deposited at the 
Federal College of Forestry, Jos, Plateau State 
with the voucher Number FHJ 101. 
 
2.2 Preparation of Extracts 
 
The plant material wasair dried under shade until 
constant weight was obtained and grinded to fine 
powdered form using a blender. 100 g of the 
powdered forms was weighed and dissolved in 
1000 ml of distilled water and boiled for 15 
minutes, allowed to cool and then filtered using 
Whatman Filter paper Grade No. 1. The filtrate 
was then allowed to dry in a water bath (50ºC). 
The extract was stored in an air tight container 
and kept until required. The methanolic, ethanolic 
and acetone extracts were prepared using similar 
methods except that 100 g of the fine powder 
was dissolved in 400 ml of the solvent 
respectively and allowed to stand for 3 h. 
Filtrates were dried at room temperature as 
against water bath in aqueous extraction. 
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Fig. 1. Image of Galega officinalis Linn (Goat’s rue) grown in Northern Nigeria 
 
2.3 Experimental Animals 
 
Male albino rats (Wistar Strain) weighing 
between 180-250 g used in this study were 
purchased from the animal house of the 
University of Jos, Nigeria and the National 
Veterinary Research Institute Vom, Nigeria.  The 
animals were maintained under standard 
conditions, had free access to food (Grand 
Cereal, Oils and Mills Products, Jos, Nigeria) and 
water ad libitum. The animals were monitored 
with care and all the experimental procedure with 
the animals was in accordance with the 
internationally accepted principles for laboratory 
animal use and the experimental protocols were 
duly approved by the ethical committee of Animal 
House of Pharmacology Department University 
of Jos, Jos.  
 
2.4 Induction of Diabetics 
 
Diabetics mellitus was induced in animals by 
single intraperitonial injection of 150 mg/kg body 
weight of alloxan monohydrate (Sigma, St. Louis, 
USA) suspended in normal saline, after an 
overnight fasting. 48 h later diabetics were 
confirmed using One Touch Glucometre. Animal 
with fasting blood glucose level ≥250 mg/dL were 
considered diabetic and included in the study. 
 
2.5 Experimental Design 
 
The study was conducted in stages; Stage I: 
Phytochemical studies from different solvents, 
Stage II: Diabetic studies of crude methanolic 
extract, Stage III: Phytochemical studies of crude 
methanolic extracts, Stage IV: Lipid profile 
studies of crude alkaloids from methanolic 
extract, Stage V: Fractionation of crude 
methanolic extract. 
 
Stage I: 
 
Crude extraction and phytochemical studies of 
different solvents extracts from G. officinalis Linn. 
using standard procedures. Phytochemicals 
screening was conducted using methods 
described by Harborne [11], Trease and Evans 
[12] and Sofowora [13]. Alkaloids, flavonoids, 
glycosides and saponins were also extracted 
from methanolic extracts of G. officinalis using 
standard procedures. 
 
Stage II: 
 
Twenty five albino rats were randomly assigned 
into five groups of five rats each and acclimatized 
for 7 days. Group A served as control and 
received 0.5 ml distilled water, orally per day. 
Group B - E were diabetic induced rats 
administered 0.5 ml distilled water, methanolic 
extract of G. officinalis, Garlic oil and           
Metformin (14.2 mg/kg bw), daily for 28             
days respectively. Glucose concentrations       
were determined at the end of the study          
period. 
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Stage III: 
 
Thirty albino rats were randomly assigned into 
six groups of five rats each and acclimatized for 
7 days. Group A served as control and received 
0.5 ml distilled water, orally per day. Group B - F 
were diabetic induced rats administered 0.5 ml 
distilled water, alkaloids, flavonoids, glycosides 
and saponins from methanolic extract of G. 
officinalis respectively and glucose 
concentrations determined at 3rd and 28th day 
post treatment. 
 
Stage IV: 
 
Fifteen albino rats were randomly assigned into 
three groups of five rats each and acclimatized 
for 7 days. Group A served as control and 
received 0.5 ml distilled water, orally per day. 
Group B and C were diabetic induced rats 
administered 0.5 ml distilled water and alkaloids 
from methanolic extract of G. officinalis 
respectively. Animals were sacrificed at the 28th 
day. Lipid profile and selected marker enzymes 
were assayed from prepared sera. 
 
Stage V: 
 
Fractions obtained from methanolic extracts of G. 
officinalis numbering seven (F1 – F7) were 
administered to experimental rats for 28 days, 
with plasma glucose determinations at 3rd and 
28th day. The grouping was as follows: Forty five 
albino rats were randomly assigned into nine 
groups of five rats each and acclimatized for 7 
days. Group A served as control and received 
0.5 ml distilled water, orally per day. Group 
Bwere diabetic induced rats administered 0.5 ml 
distilled water per day while groups C – I were 
diabetic rats administer Fractions F1 – F7 
respectively. 
 
2.6 Collection of Samples 
 
At 3rd and 28th day of treatments, whole blood 
samples were collected from animals’ tails. Using 
a One Touch® Glucometerkit, the blood glucose 
concentrations were determined. Prior to the 29th 
day, the rats were subjected to an overnight fast. 
They were anesthetized at the time of sacrifice 
by been placed in a seal cotton wool soaked in 
diethyl ether inhalation jar. Blood samples were 
collected into centrifuge tubes and allowed to clot 
for about 45 minutes, after which they were spun 
at 5000 rpm for 5 minutes, the serum collected 
were transferred into bijou bottle using pasture 
pipette and kept for analysis. 
2.7 Biochemical Parameters 
 
Biochemical parameters assayed; Total 
cholesterol concentration, serum HDL-
cholesterol and triacylglyceride were done using 
Randox diagnostic reagent kits. LDL-cholesterol 
was estimated using Friedewald formula [14]. 
Serum enzymes to include ALT and AST were 
determined by methods of Reitman and Frankel 
[15], while ALP was determined using King-
Armstrong [16]. 
 
2.8 Statistical Analysis 
 
Data were presented as Mean ± Standard 
Deviation (SD) of 5 replicates and were analyzed 
using DMRT following one-way analysis of 
variance (ANOVA) using SPSS 16.0 computer 
software package (SPSS Inc., Chicago, U.S.A). 
Differences at p<0.05 were considered 
significant. 
 
3. RESULTS 
 
The phytochemicals screening of the raw G. 
officinalis Linn using selected solvents reveal that 
alkaloids, flavonoids, tannins, cardiac glycosides, 
terpenes and steroids were present in all four 
(Aqueous, Methanolic, Ethanolic and Acetone) 
extracts (Table 1). However, saponnis and resins 
were not detected in ethanolic and acetone 
extracts but present in aqueous and methanolic 
extracts of the plant while phenols and balsam 
were detected in only ethanolic and acetone 
extracts (Table 1). 
 
Garlic oil administered to the diabetic rats 
showed a better result in lowering glucose levels 
in diabetic treated rats compared to metformin 
and methanolic extracts of G. officinalis Linn. 
However, all three treated groups had 
significantly (p<0.05) decreased glucose levels 
when compared to diabetic untreated rats       
(Table 2). 
 
Selected phytochemicals from methanolic 
extracts of G. officinalis Linn; alkaloids, 
flavonoids, glycosides and saponins 
administered at 400 mg/kgbwt/day for 28th days, 
showed varying effects on glucose 
concentrations in diabetic rats. Alkaloids, 
flavonoids and glycosides expressed significant 
(p<0.05) decrease in glucose concentrations at 
3rd Day (28.98%, 35.94%, 18.84%) and 28th Day 
(81.61%, 21.76%, 27.20%) respectively. 
Saponins obtained from the plant could not 
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express similar effect throughout the duration of 
the study (Table 3). 
 
Total Cholesterol, TG, and LDL significantly 
(p<0.05) decrease in diabetic rats treated with 
alkaloids from G. officinalis Linn. When 
compared to diabetic untreated rats with a 
corresponding significant (p<0.05) increase in 
HDL of treated rats (Table 4). 
 
The serum levels of marker enzymes (AST, ALT 
and ALP) in diabetic control (Untreated) rats 
increased significantly (p<0.05) when compared 
to the normal control rats. Alkaloid extracts 
significantly reverse these changes in the marker 
enzymes when compared to diabetic untreated 
rats (Table 5). 
 
Different fractions from methanolic extract of G. 
officinalis Linn were screened for phytochemicals 
and results presented in Table 6. Fraction 3 (F3) 
retained more of its phytochemicals with 
alkaloids, flavonoids, resins, terpenes and 
steroids present. This is closely followed by 
Fractions 2 (F2) while the least detected with a 
single phytochemical (cardiac glycosides) 
present is Fraction 1 (F1) (Table 6). 
 
Various fractions from G. officinalis Linn 
methanolic extract showed varying effect on 
serum glucose levels in alloxan-induced diabetic 
rats (Table 7). At Day 3, all fractions had 
significant (p<0.05) decrease in glucose level 
when compared to diabetic control. At Day 28, 
glucose levels were further reduced in               
diabetic treated rats especially fractions 1, 2, 3 
and 6 with 75.68%, 60.14%, 66.55% and    
72.64% decrease in glucose concentration 
(Table 7). 
 
 
Table 1. Phytochemical screening of G. officinalis Linn using selected solvents 
 
Phytochemicals Aqueous Methanol Ethanol Acetone 
Alkaloids + + + + 
Flavonoids + + + + 
Tannins + + + + 
Saponins + + - - 
Cardiac glycosides + + + + 
Terpenes and steroids + + + + 
Resins + + - - 
Phenols  - - + + 
Balsam - - + + 
Key:+ = Detected; - = Not detected 
 
Table 2. Weight variation in normal and diabetic rats 
 
Group Initial  
weight (g) 
Final  
weight (g) 
Differential 
weight (g) 
Percentage 
weight (%) 
N C 165 184 + 19 + 10.32 
D C 175 154 -22 -14.28 
D + E 160 164 + 4 + 2.44 
D + Std drug 180 171 + 9 + 5.26 
 
Table 3. Effect of G. officinalis Linn methanolic extract, garlic oil and metformin on glucose 
level in alloxan-Induced diabetic rats 
 
Group Glucose concentration (mg/dl) % Decrease in Glucose Conc. 
Normal control 77.4 ± 1.2 NA 
Diabetic control 255.4 ± 2.3b NA 
Diabetic + G. officinalis 90.0 ±  1.7c 64.84 
Diabetic + Garlic oil 81.0 ± 1.2a 68.29 
Diabetic + Metformin 91.8 ± 2.0c 64.06 
Values are mean ± SD except for % Decrease in Glucose Concentration, n=5 
a-cValues within a column with no common superscripts are significantly different (p<0.05) 
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Table 4. Effect of some phytochemicals isolated from G. officinalis Linn methanolic extract on 
glucose level in alloxan-Induced diabetic rats 
 
Groups Glucose concentration (mg/dl) % Decrease in Glucose Conc. 
3rd day 28th day 3rd day 28th day 
Normal control 86.00 ± 2.45a 81.00 ± 2.23a NA NA 
Diabetic control 345.00 ± 4.12d 386.00 ± 2.56d NA NA 
Diabetic + alkaloids 245.00 ± 1.44b 71.00 ± 2.55a 28.98 81.61 
Diabetic + flavonoids 221.00 ± 2.55b 302.00 ± 1.58c 35.94 21.76 
Diabetic + glycosides 280.00 ± 6.08c 281.00 ± 1.58b 18.84 27.20 
Diabetic + saponins 366.00 ± 1.42e 412.00 ± 2.45e -6.09 -6.74 
Values are mean±SD except for % Decrease in Glucose Concentration, n=5 
a-eValues within a column with no common superscripts are significantly different (p<0.05) 
 
Table 5. Effect of alkaloid from G. officinalis Linn methanolic extract on lipid profile in  
alloxan-induced diabetic rats 
 
Groups Lipid profile (Mmol/L) 
Total Chol. TG HDL LDL 
Normal control 0.50 ± 0.01a 0.90 ± 0.05a 2.20 ± 0.02a 0.80 ± 0.08a 
Diabetic control 2.40 ± 0.08b 2.70 ± 0.08b 0.67 ± 0.05b 2.94 ± 0.01b 
Diabetic + Alkaloid 0.90 ± 0.10c 1.10 ± 0.50a 2.51 ± 0.10c 1.24 ± 0.06c 
Values are Mean ± S.D, n=5 
a-cValues within a column with no common superscripts are significantly different (p<0.05) 
 
Table 6. Effect of alkaloid from G. officinalis Linn methanolic extract on some serum enzymes 
in alloxan-Induced diabetic rat 
 
Groups Selected marker enzymes (Mmol/L) 
AST  ALT ALP 
Normal control 274.33 ± 1.10a 103.33 ± 1.10a 208.00 ± 0.82a 
Diabetic control 471.64 ± 2.25b 133.33 ± 1.20b 363.33 ± 2.0b 
Diabetic + Alkaloid 277.50 ± 2.01a 106.20 ± 1.10a 210.10 ± 1.50a 
Values are Mean ± S.D, n=5 
a-cValues within a column with no common superscripts are significantly different (p<0.05) 
 
Table 7. Phytochemical screening of the fractions of G. officinalis Linn methanolic extracts 
 
Phytochemicals Fractions 
F1 F2 F3 F4 F5 F6 F7 
Alkaloids - + + - - - - 
Flavonoids - + + - - - - 
Tannins - - - - + + + 
Saponins - - - - - + + 
Cardiac glycosides + - - - - - - 
Terpenes and steroids - + + + - - - 
Resins - - + + + - - 
Key: + = Detected - = Not detected 
 
4. DISCUSSION 
 
Diabetes Mellitus (DM) describes a metabolic 
disorder of multiple aetiology, it is characterized 
by chronic hyperglycaemia with disturbances of 
carbohydrate, fat and protein metabolism 
resulting from defects in insulin secretion, insulin 
action, or both. DM is a common endocrine 
disorder in which there occur increased food and 
water intake [17], it is a growing health concern 
worldwide [18]. The effects of diabetes mellitus 
include long-term damage, dysfunction and 
failure of various organs. Diabetes mellitus may 
present with characteristic symptoms such as 
thirst, polyuria, blurring of vision, and weight loss 
[19,20]. The present study wish to contribute to
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Table 8. Effect of different fractions of G. officinalis Linn methanolic extract on glucose level in 
alloxan-Induced diabetic rats 
 
Fractions Glucose concentration (mg/dl) % Decrease in glucose Conc. 
3rd day 28th day 3rd day 28th day 
Normal control 85 ± 1.12a 87 ± 1.10a NA NA 
Diabetic control 258 ± 1.23b 296 ± 2.11d NA NA 
Diabetic + F1 175 ± 1.35c 72 ± 1.10a 32.17 75.68 
Diabetic + F2 198 ± 1.32e 118 ± 1.21c 23.26 60.14 
Diabetic + F3 197 ± 1.33e 99 ± 1.22b 23.64 66.55 
Diabetic + F4 168 ± 1.10d 216 ± 2.41e 34.88 27.03 
Diabetic + F5 148 ± 1.22c 119 ± 1.33c 42.63 32.77 
Diabetic + F6 151 ± 1.12c 81 ± 1.22a 41.47 72.64 
Diabetic + F7 201 ± 2.32e 212 ± 2.22e 22.09 28.38 
Values are mean ± SD except for % Decrease in Glucose Concentration, n=5 
a-eValues within a column with no common superscripts are significantly different (p<0.05) 
 
the knowledge of G. officinalis in treatment of DM 
by a bio-guided fractionation of crude extracts of 
the plant. 
 
The phytochemicals screening of the raw G. 
officinalis Linn using selected solvents reveals 
that alkaloids, flavonoids, tannins, cardiac 
glycosides, terpenes and steroids were present 
in all four (Aqueous, Methanolic, Ethanolic       
and Acetone) extracts (Table 1). Several 
phytochemicals including alkaloids, flavonoids, 
glycosides, glycolipid, steroids, carbohydrates, 
glycopeptides, terpenoids, amino acids, saponins 
and inorganic ions are known to affect various 
metabolic pathways, which in turn directly or 
indirectly affect the level of glucose in the human 
body [21,22]. G. officinalis prove to be rich in 
such phytochemicals which may produce potent 
hypoglycemic, anti-hyperglycemic and glucose 
suppressive activities. 
 
Sharp difference was observed after induction of 
diabetes in the experimental rats as shown in 
Table 2. The normal control showed a significant 
increase in body weight whiles the diabetic 
control group, treatment groups showed a 
decrease in body weight. 
 
Diabetic studies of crude methanolic extract of G. 
officinalis revealed the antidiabetic potentials of 
the plant. Methanolic extract from G. officinalis 
lowered the high blood glucose in diabetic rats in 
a similar manner with the reference drug 
metformin (Table 3). Garlic oil however, 
significantly expressed a better effect. A similar 
result of the effect of garlic oil on some 
biochemical parameters in diabetic induced rats 
has also been documented [23,24]. The above 
effects achieved by methanolic extract of G. 
officinalis is either by increasing serum levels of 
insulin or increasing the production of insulin 
from pancreatic β-cells, inhibit glucose 
absorption in the gut, stimulate glycogenesis in 
liver or increase glucose utilization by the body 
[21,22,25]. G. officinalis (Goat’s rue) contains an 
alkaloid called Galegin which is key to its 
extraordinary anti diabetic effects. Galegin is 
chemically similar to Guanidine, the standard 
compound from which many conventional 
diabetic drugs are manufactured, such as 
metformin [26,27]. Ward, [28] also reported that 
the chemical benefits of G. officinalis on diabetic 
model are similar to that of metformin. 
 
Alkaloids, flavonoids, glycosides and saponins 
were further extracts from methanolic extract of 
G. officinalis. Administration of these 
phytochemicals at a dosage of 400 mg/kg 
bwt./day for 28th days, showed varying effects on 
glucose concentrations in diabetic rats (Table 4). 
Alkaloids, flavonoids and glycosides expressed 
significant (p<0.05) decrease in plasma glucose 
concentrations at Day 3 and Day 28. Flavonoids 
present a 35.94% and 21.76% decrease 
respectively, expressing their natural 
hypoglycemic properties. It has been reported 
that some flavonoids possess hypoglycemic 
properties because they improve altered glucose 
and oxidative metabolism of the diabetic states 
[29]. However, at day 28, alkaloids produced 
81.61% decrease in glucose concentration. 
These promising result increase our curiosity in 
investigating the effects of alkaloids from 
Methanolic extract of G. officinalis on lipid profile 
and selected marker enzymes in alloxan-induced 
diabetic rats (Table 5 and Table 6). 
 
Alterations in serum lipid profile in diabetes are 
likely to increase the risk of coronary heart 
disease [30]. Significant (p<0.05) reduction in 
  
 
 
Luka et al.; EJMP, 19(1): 1-10, 2017; Article no.EJMP.32145 
 
 
 
8 
 
serum lipids; total cholesterol, triglyceride and 
low density lipoprotein level in diabetic rats 
treated with alkaloids from methanolic extract of 
G. officinalis Linn should be considered as 
beneficial in long term prognosis of diabetes. 
Alterations in lipid metabolism; hypertriacyl-
glycerolemia and hypercholesterolemia, as 
observed in diabetic untreated rats usually 
contribute to the pathogenesis of vascular 
complications in diabetes [31,32]. Alkaloids from 
methanolic extracts of G. officinalis Linn 
significantly (p<0.05) reverse these alterations in 
lipid metabolism and also restore the protective 
role of HDL- cholesterol (Table 4). 
 
The levels of AST, ALT and ALP were 
significantly (p<0.05) increased in alloxan-
induced diabetic untreated rats (Table 6) as 
previously reported [33,34]. Alkaloid extracts 
from G. officinalis Linn significantly reverse these 
changes in the marker enzymes when compared 
to diabetic untreated rats. 
 
The last stage of this study involves the 
fractionation of methanolic extracts of G. 
officinalis Linn resulting in seven (7) fractions 
which were subjected to phytochemical 
screening and hypoglycaemic studies (Table 7 
and Table 8). Fraction 3 (F3) retained more of its 
phytochemicals with alkaloids, flavonoids, resins, 
terpenes and steroids present and produced 
66.55% decrease in glucose concentrations at 
day 28. These compounds (phytochemicals) may 
be responsible for the hypolipidemic effect and 
restoration of enzymatic functions [35] as 
supported by the data obtained. Alkaloids 
produced 81.61% reduction in glucose while 
crude methanolic extract produced 64.84% 
reduction in glucose when compared with 
diabetic untreated rats. Alkaloids from the 
methanolic extract could be responsible for the 
hypoglycemic properties of G. officinalis. None of 
the fractions could produce a greater effect as 
alkaloids from the methanolic extract at the 28th 
day of treatment. 
 
5. CONCLUSION 
 
G. officinalis proved to be a rich source of 
phytochemicals and also revealed its antidiabetic 
potentials in experimental rats. Water, methanol, 
ethanol and acetone were able to extract a quit 
number of phytochemicals from the plant with the 
methanolic extract expressing a similar effect as 
metformin in diabetic treated rats. Furthermore, 
the methanolic extracts significantly improved the 
lipid profile and reverse adverse effect of 
diabetics on serum enzymes (AST, ALT and 
ALP). At day 28, fractions F1, F2, F3 and 
F6obtained from the methanolic extract of G. 
officinalis produced remarkable effect by 
decreasing glucose concentration in diabetic 
treated rats. 
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